Your browser doesn't support javascript.
loading
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours.
Maity, Amit; Mick, Rosemarie; Huang, Alexander C; George, Sangeeth M; Farwell, Michael D; Lukens, John N; Berman, Abigail T; Mitchell, Tara C; Bauml, Josh; Schuchter, Lynn M; O'Hara, Mark; Lin, Lilie L; Demichele, Angela; Christodouleas, John P; Haas, Naomi B; Patsch, Dana M; Hahn, Stephen M; Minn, Andy J; Wherry, E John; Vonderheide, Robert H.
Afiliação
  • Maity A; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. maity@uphs.upenn.edu.
  • Mick R; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. maity@uphs.upenn.edu.
  • Huang AC; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • George SM; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Farwell MD; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Lukens JN; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Berman AT; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Mitchell TC; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Bauml J; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Schuchter LM; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • O'Hara M; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Lin LL; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Demichele A; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Christodouleas JP; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Haas NB; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Patsch DM; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Hahn SM; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Minn AJ; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Wherry EJ; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Vonderheide RH; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Br J Cancer ; 119(10): 1200-1207, 2018 11.
Article em En | MEDLINE | ID: mdl-30318516
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Quimiorradioterapia / Hipofracionamento da Dose de Radiação / Antineoplásicos Imunológicos / Neoplasias Pulmonares / Melanoma Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Quimiorradioterapia / Hipofracionamento da Dose de Radiação / Antineoplásicos Imunológicos / Neoplasias Pulmonares / Melanoma Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article